Ser1178
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser1178  -  eNOS (rat)

Site Information
RIRtQsFsLQERQLR   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 467802

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 1 , 2 ) , western blotting ( 1 , 2 )
Relevant cell line - cell type - tissue:
adipocyte ( 2 ) , kidney ( 1 )

Upstream Regulation
Treatments:
Akt-I-1 ( 2 ) , estradiol ( 2 ) , H-89 ( 2 ) , insulin ( 2 ) , ischemia/reperfusion ( 1 ) , spironolactone ( 1 ) , U0126 ( 2 ) , wortmannin ( 2 )

Downstream Regulation
Effects of modification on eNOS:
enzymatic activity, induced ( 1 )

References 

1

Mejía-Vilet JM, et al. (2007) Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293, F78-86
17376767   Curated Info

2

Jaubert AM, et al. (2007) Nongenomic estrogen effects on nitric oxide synthase activity in rat adipocytes. Endocrinology 148, 2444-52
17303666   Curated Info